Phase 3 Study of BK1310 in Healthy Infants

Clinical trial NCT02992925 · COMPLETED

Trial details

NCT number: NCT02992925
Sponsor: Tanabe Pharma Corporation
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Immunization; Infection

Start date: 2016-11-01
Primary completion: 2017-12-01
Enrollment: 370

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.